Strategies for Diagnosis &Treatment

Diagnosis and the treatment of a rare disease become complicated because of the fact that many health care providers may have restricted involvement with the identification of the particular disease condition with the diagnosis of rare diseases. Additionally, analysis before manifestation onset or diagnosis early stage in the disease can be challenging. Biopharmaceutical specialists in the field have utilized new advances and the developing exploratory comprehension of multiple rare diseases to develop and diagnose ground breaking therapies over the last 10 years. In the last decade, more than 230 new orphan medical drugs were approved by the U.S. Food and Drug Administration (FDA). In 2015 alone, about half (47%) of novel latest drug approvals were for rare diseases. Disease specific therapies need to be developed for productive results in treatment of Rare Diseases.

  • Radiology & CT,CAT Scan
  • Medical Imaging
  • Neurodevelopmental assessments
  • Physical and neurological exams
  • Cognitive testing
  • Neurophysiologic testing
  • Clinical testing
  • Nutrition and diet modification
  • Orphan drugs

Related Conference of Strategies for Diagnosis &Treatment

June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands
August 28-29, 2025

8th Pathology and Infectious Disease Conference

London, UK
September 22-23, 2025

11th International Conference on Infectious and Rare Diseases

Vancouver, Canada
December 11-12, 2025

8th Annual Congress on Bacterial, Viral and Infectious Diseases

Prague, Czech Republic

Strategies for Diagnosis &Treatment Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in